The Nebraska Medical Center is a clinical research site located in Omaha, Nebraska, United States 68198.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
The Nebraska Medical Center has participated in 25 clinical trials with 3 currently active.
Therapeutic areas: Stroke, Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL).
Sponsors: Boston Scientific Corporation, Genzyme, a Sanofi Company, Vertex Pharmaceuticals Incorporated.
Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
The Nebraska Medical Center has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Nebraska Medical Center has 25 clinical trials on record, with 3 currently active. Their work covers Stroke, Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL).
Yes — The Nebraska Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.